Show
Sort by
-
- Journal Article
- A1
- open access
Ferroptosis and pyroptosis signatures in critical COVID-19 patients
-
- Journal Article
- A1
- open access
Questionnaire PLD‐complaint‐specific assessment identifies need for therapy in polycystic liver disease : a multi‐centric prospective study
-
- Journal Article
- A1
- open access
PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis
-
- Journal Article
- A1
- open access
The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology
-
Sustained off-treatment viral control is associated with high hepatitis B surface antigen seroclearance rates in Caucasian patients with nucleos(t)ide analogue-induced HBeAg seroconversion
-
- Journal Article
- A1
- open access
Caucasian ethnicity, but not treatment cessation is associated with HBsAg loss following nucleos(t)ide analogue-induced HBeAg seroconversion
-
- Journal Article
- A1
- open access
Stopping nucleos(t)ide analogue treatment in Caucasian hepatitis B patients after HBeAg seroconversion is associated with high relapse rates and fatal outcomes
-
- Journal Article
- A1
- open access
Efficacy, safety and pharmacokinetics of simeprevir and TMC647055/ritonavir with or without ribavirin and JNJ-56914845 in HCV genotype 1 infection
-
- Journal Article
- A1
- open access
Elafibranor, an agonist of the peroxisome proliferator−activated receptor−α and −δ, induces resolution of nonalcoholic steatohepatitis without fibrosis worsening
-
Belgian experience with triple therapy with boceprevir and telaprevir in genotype 1 infected patients who inject drugs